MCAM is a long-acting medication that can prevent opioid overdose by blocking the effects of opioids for days or even weeks.

Boston has hit a tipping point. City taxpayers deserve a coordinated response by the State Police, Boston Police, DEA, FBI, ...

The U.S. Food and Drug Administration sent letters to seven companies that sell opioid alternative products containing ...

R ICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

The Food and Drug Administration is taking a closer look at kratom extracts and preparing to ask Congress for expanded ...

Companies that manufacture powerful, long-acting opioid painkillers will have to sponsor education programs about how to appropriately prescribe their drugs, according to the FDA.

The FDA approved the first new class of non-opioid painkillers in more than two decades, the agency said Thursday. Suzetrigine, branded as Journavx, works to block receptors before they reach the ...